Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Quak

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|July 15, 1990
Identification of a 43-kDa nuclear antigen associated with proliferation by monoclonal antibody K 112J J Quak, G van Dongen, M A Koken, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neckD R Colnot, J J Quak, J C Roos, et al.
International Journal of Cancer|September 15, 1988
Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistanceR J Scheper, J W Bulte, J G Brakkee, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|August 26, 2006
The prognostic value of severe malnutrition in the development of nonthyroidal illness in head and neck cancer patientsM P C Siroen, M A E van Bokhorst-de van der Schueren, M C Richir, et al.
International Journal of Cancer|February 15, 1989
Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistanceH J Broxterman, H M Pinedo, C M Kuiper, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Differences in immune status between well-nourished and malnourished head and neck cancer patientsM A van Bokhorst-De van der Schuer, B M von Blomberg-van der Flier, R K Riezebos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2R de Bree, J C Roos, J J Quak, et al.
Cancer Research|May 1, 1992
Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2G A van Dongen, H Leverstein, J C Roos, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 9, 2000
Survival of malnourished head and neck cancer patients can be predicted by human leukocyte antigen-DR expression and interleukin-6/tumor necrosis factor-alpha response of the monocytevan Bokhorst-de van der Schuer, B M von Blomberg-van der Flier, D J Kuik, et al.
European Journal of Nuclear Medicine|November 3, 1998
The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patientsR de Bree, D J Kuik, J J Quak, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|July 15, 1990
Identification of a 43-kDa nuclear antigen associated with proliferation by monoclonal antibody K 112J J Quak, G van Dongen, M A Koken, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neckD R Colnot, J J Quak, J C Roos, et al.
International Journal of Cancer|September 15, 1988
Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistanceR J Scheper, J W Bulte, J G Brakkee, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|August 26, 2006
The prognostic value of severe malnutrition in the development of nonthyroidal illness in head and neck cancer patientsM P C Siroen, M A E van Bokhorst-de van der Schueren, M C Richir, et al.
International Journal of Cancer|February 15, 1989
Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistanceH J Broxterman, H M Pinedo, C M Kuiper, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Differences in immune status between well-nourished and malnourished head and neck cancer patientsM A van Bokhorst-De van der Schuer, B M von Blomberg-van der Flier, R K Riezebos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2R de Bree, J C Roos, J J Quak, et al.
Cancer Research|May 1, 1992
Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2G A van Dongen, H Leverstein, J C Roos, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 9, 2000
Survival of malnourished head and neck cancer patients can be predicted by human leukocyte antigen-DR expression and interleukin-6/tumor necrosis factor-alpha response of the monocytevan Bokhorst-de van der Schuer, B M von Blomberg-van der Flier, D J Kuik, et al.
European Journal of Nuclear Medicine|November 3, 1998
The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patientsR de Bree, D J Kuik, J J Quak, et al.
Pageof 5